Gender differences in the association of sleep apnea and inflammation

Brain, Behavior, and Immunity

Volumn 47, Issue , 2015, Pages 211-217

  Gaines, Jordan ^a   Vgontzas, Alexandros N ^a   Fernandez Mendoza, Julio ^a   Kritikou, Ilia ^a   Basta, Maria ^b   Bixler, Edward O ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Apnea; CRP; Gender; Hypertension; Inflammation; Sleep

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR RECEPTOR 1; ADIPOQ PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; BLOOD; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; SEXUAL DEVELOPMENT;

ADIPONECTIN; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SEX CHARACTERISTICS; SLEEP APNEA SYNDROMES;

EID: 84930756063     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.11.013     Document Type: Article

References (51)

1. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 1990, 4:2860-2867.
2. Basta M., Lin H.M., Pejovic S., Sarrigiannidis A., Bixler E.O., Vgontzas A.N. Lack of regular exercise, depression, and degree of apnea are predictors of excessive daytime sleepiness in patients with sleep apnea: sex differences. J. Clin. Sleep Med. 2008, 4:19-25.
3. Bixler E.O., Vgontzas A.N., Lin H.M., Ten Have T., Leiby B.E., Vela-Bueno A., Kales A. Association of hypertension and sleep-disordered breathing. Arch. Intern. Med. 2000, 160:2289-2295.
4. Bixler E.O., Vgontzas A.N., Lin H.M., Ten Have T., Rein J., Vela-Bueno A., Kales A. Prevalence of sleep-disordered breathing in women: effects of gender. Am. J. Respir. Crit. Care Med. 2001, 163:608-613.
5. Bixler E.O., Vgontzas A.N., Ten Have T., Tyson K., Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am. J. Respir. Crit. Care Med. 1998, 157:144-148.
6. Böttner A., Kratzsch J., Müller G., Kapellen T.M., Blüher S., Keller E., Blüher M., Kiess W. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J. Clin. Endocrinol. Metab. 2004, 89:4053-4061.
7. Cartier A., Côte M., Lemieux I., Pérusse L., Tremblay A., Bouchard C., Després J. Sex differences in inflammatory markers: what is the contribution of visceral adiposity?. Am. J. Clin. Nutr. 2009, 89:1307-1314.
8. Couillard C., Mauriège P., Prud'homme D., Nadeau A., Tremblay A., Bouchard C., Després J.P. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 1997, 40:1178-1184.
9. Dancey D.R., Hanly P.J., Soong C., Lee B., Hoffstein V. Impact of menopause on the prevalence and severity of sleep apnea. Chest 2001, 120:151-155.
10. Doran B., Zhu W., Muennig P. Gender differences in cardiovascular mortality by C-reactive protein level in the United States. Am. Heart J. 2013, 166:45-51.
11. Gavrila A., Peng C.K., Chan J.L., Mietus J.E., Goldberger A.L., Mantzoros C.S. Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J. Clin. Endocrinol. Metab. 2003, 88:2838-2843.
12. Hedner J., Bengtsson-Boström K., Peker Y., Grote L., Råstam L., Linblad U. Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur. Respir. J. 2006, 27:564-570.
13. Hellström L., Wahrenberg H., Hruska K., Reynisdottir S., Arner P. Mechanisms behind gender differences in circulating leptin levels. J. Intern. Med. 2000, 247:457-462.
14. Hickey M.S., Israel R.G., Gardiner S.N., Considine R.V., McCammon M.R., Tyndall G.L., Houmard J.A., Marks R.H., Caro J.F. Gender differences in serum leptin levels in humans. Biochem. Mol. Med. 1996, 59:1-6.
15. Hinojosa-Laborde C., Mifflin S.W. Sex differences in blood pressure response to intermittent hypoxia in rats. Hypertension 2005, 46:1016-1021.
16. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today 1990, 11:443-449.
17. Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 2010, 11:11-18.
18. Ishikawa I., Hoshide S., Eguchi K., Ishikawa S., Pickering T.G., Shimada K., Kario K. Increased low-grad inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome. J. Hypertens. 2008, 26:1181-1187.
19. Kapsimalis F., Kryger M.H. Gender and obstructive sleep apnea syndrome, part I: Clinical features. Sleep 2002, 25:409-416.
20. Kato I., Toniolo P., Akhmedkhanov A., Koenig K.L., Shore R., Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J. Clin. Endocrinol. Metab. 1998, 51:1271-1276.
21. Kennedy A., Gettys T.W., Watson P., Wallace P., Ganaway E., Pan Q., Garvey W.T. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J. Clin. Endocrinol. Metab. 1997, 82:1293-1300.
22. Khera A., McGuire D.K., Murphy S.A., Stanek H.G., Das S.R., Vongpatansin W., Wians F.H., Grundy S.M., de Lemos J.A. Race and gender differences in C-reactive protein levels. J. Am. Coll. Cardiol. 2005, 46:464-469.
23. Kritikou I., Basta M., Tappouni R., Pejovic S., Fernandez-Mendoza J., Nazir R., Shaffer M., Liao D., Bixler E.O., Chrousos G.P., Vgontzas A.N. Sleep apnoea and visceral adiposity in middle-aged male and female subjects. Eur. Respir. J. 2013, 41:601-609.
24. Kritikou I., Basta M., Vgontzas A.N., Pejovic S., Liao D., Tsaoussoglou M., Bixler E.O., Stefanakis Z., Chrousos G.P. Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur. Respir. J. 2014, 43:145-155.
25. Lakoski S.G., Cushman M., Criqui M., Rundek T., Blumenthal R.S., D'Agostino R.B., Herrington D.M. Gender and C-reactive protein: data from the multiethnic study of atherosclerosis (MESA) cohort. Am. Heart. J. 2006, 152:593-598.
26. Langendonk J.G., Pijl H., Toornvliet A.C., Burggraaf J., Frölich M., Schoemaker R.C., Doornbos J., Cohen A.F., Meinders A.E. Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss. J. Clin. Endocrinol. Metab. 1998, 83:1706-1712.
27. Lemieux S., Prud'homme D., Bouchard C., Tremblay A., Després J. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am. J. Clin. Nutr. 1993, 58:463-467.
28. Ley C.J., Lees B., Stevenson J.C. Sex- and menopause-associated changes in body-fat distribution. Am. J. Clin. Nutr. 1992, 55:950-954.
29. McConnell J.P., Branum E.L., Ballman K.V., Lagerstedt S.A., Katzmann J.A., Jaffe A.S. Gender differences in C-reactive protein concentrations-confirmation with two sensitive methods. Clin. Chem. Lab. Med. 2002, 40:56-59.
30. Meier-Ewert H.K., Ridker P.M., Rifai N., Price N., Dinges D.F., Mullington J.M. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin. Chem. 2001, 47:426-430.
31. Mohsenin V., Yaggi H.K., Shah N., Dziura J. The effect of gender on the prevalence of hypertension in obstructive sleep apnea. Sleep Med. 2009, 10:759-762.
32. National Institute on Aging, 2008. Menopause: Time for a Change. U.S. Department of Health and Human Services, Publication #08-6143, p. 4.
33. Nieto F.J., Young T.B., Lind B.K., Shahar E., Samet J.M., Redline S., D'Agostino R.B., Newman A.B., Lebowitz M.D., Pickering T.G. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000, 283:1829-1836.
34. Ostlund R.E., Yang J.W., Klein S., Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J. Clin. Endocrinol. Metab. 1996, 81:3909-3913.
35. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 2000, 342:1378-1384.
36. Phillips B., Collop N.A., Drake C., Consens F., Vgontzas A.N., Weaver T.E. Sleep disorders and medical conditions in women. J. Womens Health 2008, 17:1191-1199.
37. Rechtschaffen A., Kales A. Manual of standardized terminology, techniques and scoring system for sleep stages of human subjects 1968, NIH Publication 204, Washington D.C.
38. Redline S., Yenokyan G., Gottlieb D.J., Shahar E., O'Connor G.T., Resnick H.E., Diener-West M., Sanders M.H., Wolf P.A., Geraghty E.M., Ali T., Lebowitz M., Punjabi N.M. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am. J. Respir. Crit. Care Med. 2010, 182:269-277.
39. Sahlman J., Miettinen K., Peuhkurinen K., Seppä J., Peltonen M., Herder C., Punnonen K., Vanninen E., Gylling H., Partinen M., Uusitupa M., Tuomilehto H. Kuopio Sleep Aponoea Group. J. Sleep Res. 2010, 19:341-348.
40. Saltevo J., Kautiainen H., Vanhala M. Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes. Gend. Med. 2009, 6:463-470.
41. Saltiel A.R., Kahn C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
42. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., Wolk R., Kara T., Accurso V., Somers V.K. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105:2462-2464.
43. Song H.J., Oh S., Quan S., Ryu O.H., Jeong J.Y., Hong K.S., Kim D.H. Gender differences in adiponectin levels and body composition in older adults: Hallym aging study. BMC Geriatr. 2014, 14. 10.1186/1471-2318-14-8.
44. Uthgenannt D., Schoolmann D., Pietrowsky R., Fehm H.L., Born J. Effects of sleep on the production of cytokines in humans. Psychosom. Med. 1995, 57:97-104.
45. Vgontzas A.N., Bixler E.O., Chrousos G.P. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med. Rev. 2005, 9:211-224.
46. Vgontzas A.N., Bixler E.O., Lin H.M., Prolo P., Trakada G., Chrousos G.P. IL-6 and its circadian secretion in humans. Neuroimmunomodulation 2005, 12:131-140.
47. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Hopper K., Lotsikas A., Lin H.M., Kales A., Chrousos G.P. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J. Clin. Endocrinol. Metab. 2000, 85:1151-1158.
48. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 1997, 82:1313-1316.
49. Vgontzas A.N., Zoumakis E., Bixler E.O., Lin H.M., Collins B., Basta M., Pejovic S., Chrousos G.P. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur. J. Clin. Invest. 2008, 38:585-595.
50. Wener M.H., Daum P.R., McQuillan G.M. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J. Rheumatol. 2002, 27:2351-2359.
51. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 1993, 328:1230-1235.